Photodynamic Diagnosis-Assisted Transurethral Resection - Lights Out?

NEJM Evid. 2022 Oct;1(10):EVIDe2200194. doi: 10.1056/EVIDe2200194. Epub 2022 Sep 27.

Abstract

In a randomized trial and accompanying cost-effectiveness analysis, conducted in people with suspected urothelial carcinoma of the bladder, Heer at al.1 in this issue of NEJM Evidence compare transurethral resection aided by intravesical installation of a photosensitizer with the same procedure guided by standard white light. The study's main finding was that the photosensitizer-based approach was not associated with a reduction of time to recurrence of tumor. Moreover, patients undergoing the photosensitizer-based procedure had only a small absolute risk reduction (3.8 percentage points; 95% confidence interval [CI], -13.4 to 6.6) of tumor recurrence in the trial time frame.

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Carcinoma, Transitional Cell* / pathology
  • Humans
  • Neoplasm Recurrence, Local
  • Photosensitizing Agents
  • Randomized Controlled Trials as Topic
  • Urinary Bladder / pathology
  • Urinary Bladder Neoplasms* / pathology

Substances

  • Photosensitizing Agents